Time-varying effect moderation using the structural nested mean model: Estimation using inverse-weighted regression with residuals

Statistics in Medicine

Volumn 33, Issue 20, 2014, Pages 3466-3487

  Almirall, Daniel ^a   Griffin, Beth Ann ^b   McCaffrey, Daniel F ^b   Ramchand, Rajeev ^b   Yuen, Robert A ^a   Murphy, Susan A ^a,c  

^a UNIVERSITY OF MICHIGAN   (United States)

^b RAND CORPORATION   (United States)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Effect modification; Inverse probability of treatment weighting; Time varying confounding; Time varying covariates; Time varying exposure; Time varying treatment

Indexed keywords

ANALYTICAL ERROR; ARTICLE; CALCULATION; DATA ANALYSIS; LINEAR SYSTEM; LONGITUDINAL STUDY; OBSERVATIONAL STUDY; PROBABILITY; QUANTITATIVE ANALYSIS; REGRESSION ANALYSIS; SIMULATION; STATISTICAL DISTRIBUTION; STATISTICAL MODEL; STRUCTURAL NESTED MEAN MODEL; ADOLESCENT; COMPUTER SIMULATION; EPIDEMIOLOGY; FEMALE; HUMAN; MALE; STATISTICAL ANALYSIS; SUBSTANCE-RELATED DISORDERS; TIME; TREATMENT OUTCOME;

ADOLESCENT; CAUSALITY; COMPUTER SIMULATION; CONFOUNDING FACTORS (EPIDEMIOLOGY); DATA INTERPRETATION, STATISTICAL; EFFECT MODIFIER, EPIDEMIOLOGIC; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MODELS, STATISTICAL; REGRESSION ANALYSIS; SUBSTANCE-RELATED DISORDERS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84905447624     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.5892     Document Type: Article

References (53)

1. Almirall D, McCaffrey D, Ramchand R, Murphy S. Subgroups analysis when treatment and moderators are time-varying. Prevention Science 2011; 14(2):169-178.
2. Almirall D, TenHave T, Murphy S. Structural nested mean models for assessing time-varying effect moderation. Biometrics 2009; 66(1):131-139.
3. Petersen M, Deeks S, Martin J, vander Laan M. History-adjusted marginal structural models to estimate time-varying effect modification. American Journal of Epidemiology 2007; 166(9):985-93.
4. Robins JM, Hernán MA, Rotnitzky A. Invited commentary on 'history-adjusted marginal structural models to estimate time-varying effect modification'. American Journal of Epidemiology 2007; 166(9):994-1002.
5. Petersen M, vander Laan M. Response to invited commentary on 'history-adjusted marginal structural models to estimate time-varying effect modification'. American Journal of Epidemiology 2007; 166(9):1003-1004.
6. Murphy SA, vander Laan MJ, Robins JM, CPPRG. Marginal mean models for dynamic regimes. Journal of the American Statistical Association 2001; 96:1410-1423.
7. Murphy S, Almirall D. Dynamic treatment regimens. In Encyclopedia of Medical Decision Making, Kattan MW (ed.). Sage Publications: Thousand Oaks, CA, 2009; 419-422.
8. Baron R, Kenny D. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. Journal of Personality and Social Psychology 1986; 51:1173-1182.
9. Kraemer HC, Wilson G, Fairburn C. Mediators and moderators of treatment effects in randomized clinical trials. Archives of General Psychiatry 2002; 59:877-883.
10. Robins JM. Causal inference from complex longitudinal data. In Latent Variable Modeling and Applications to Causality, Lecture Notes in Statistics. Springer-Verlag: New York, 1997; 69-117.
11. Robins JM. Association, causation, and marginal structural models. Synthese 1999; 121:151-179.
12. Robins JM, Hernan MA, Brumback B. Marginal structural models and causal inference in epidemiology. Epidemiology 2000; 11(5):550-560.
13. Hernán MA, Brumback B, Robins JM. Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men. Epidemiology 2000; 11(5):561-570.
14. Cole SR, Hernán MA, Robins JM, Anastos K, Chmiel J, Detels R, Ervin C, Feldman J, Greenblatt R, Kingsley L, Lai S, Young M, Cohen M, Muñoz A. Effect of highly active antiretroviral therapy on time to acquired immunodeficiency syndrome or death using marginal structural models. American Journal of Epidemiology 2003; 158(7):687-694.
15. Robins JM. A graphical approach to the identification and estimation of causal parameters in mortality studies with sustained exposure periods. Journal of Chronic Disease 1987; 40(Supplement 2):139s-161s.
16. Robins JM. The control of confounding by intermediate variables. Statistics in Medicine 1989; 8:679-701.
17. Robins JM. Correcting for non-compliance in randomized trials using structural nested mean models. Communications in Statistics, Theory and Methods 1994; 23:2379-2412.
18. Robins JM. Estimating causal effects of time-varying endogenous treatments by g-estimation of structural nested models. In Latent Variable Modeling and Applications to Causality, Berkane M (ed.), Lecture Notes in Statistics. Springer: New York, 1997; 69-117.
19. Pearl J. Graphs, causality, and structural equation models. Sociological Methods and Research 1998; 27:226-284.
20. Cole S, Platt R, Schisterman E, Chu H, Westreich D, Richardson D, Poole C. Illustrating bias due to conditioning on a collider. International Journal of Epidemiology 2010; 39:417-420.
21. Murphy S. An experimental design for the development of adaptive treatment strategies. Statistics in Medicine 2005; 24(10):1455-1481.
22. Almirall D, Coffman C, Yancy W, Murphy S. Maximum likelihood estimation of the structural nested mean model using SAS PROC NLP. In Analysis of Observational Health-Care Data Using SAS, Faries D, Leon A, Haro J, Obenchain B (eds). SAS Press: Cary, NC, 2010; 231-261.
23. Henderson R, Ansell P, Alshibani D. Regret-regression for optimal dynamic treatment regimes. Biometrics 2010; 66(4):1192-201.
24. Henderson R, Ansell P, Alshibani D. Optimal dynamic treatment methods. REVSTAT Statistical Journal 2011; 9(1):19-36.
25. vander Laan MJ, Murphy SA, Robins JM. Analyzing dynamic regimes using structural nested mean models, 2002. Unpublished Manuscript.
26. vander Laan MJ, Robins JM. Unified Methods for Censored Longitudinal Data and Causality, Series in Statistics. Springer-Verlag: New York, NY, 2003.
27. Robins JM. Optimal structural nested models for optimal sequential decisions. In Proceedings of the Second Seattle Symposium on Biostatistics, Lin D, Heagerty P (eds). Springer: New York, NY, 2004; 189-326.
28. Rubin DB. Estimating causal effects of treatments in randomized and nonrandomized studies. Journal of Educational Psychology 1974; 66(5):688-701.
29. Holland P. Statistics and causal inference. Journal of the American Statistical Association 1986; 81:945-970.
30. VanderWeele TJ. Mediation and mechanism. European Journal of Epidemiology 2009; 24(5):217-224.
31. VanderWeele TJ, Vansteelandt S. Conceptual issues concerning mediation, interventions and composition. Statistics and Its Interface 2009; 2:457-468.
32. McCullagh P, Nelder J. Generalized Linear Models, 2nd edn. Chapman and Hall/CRC: Boca Raton, FL, 1989.
33. Rosthøj S, Keiding N, Schmiegelow K. Estimation of dynamic treatment strategies for maintenance therapy of children with acute lymphoblastic leukaemia: an application of history-adjusted marginal structural models. Statistics in Medicine 2009; 31(5):470-488.
34. Cohen J. Statistical Power Analysis for the Behavioral Sciences, 2nd edn. Lawrence Earlbaum Associates: Hillsdale, New Jersey, 1988.
35. Dennis ML, Titus JC, White MK, Unsicker JI, Hodgkins D. Global Appraisal of Individual Needs (GAIN): Administration guide for the GAIN and related measures, Chestnut Health Systems, Bloomington, IL: Chestnut Health Systems, 2002. Available online at http://www.chestnut.org/li/gain.
36. Almirall D, McCaffrey DF, Griffin BA, Ramchand R, Yuen RA, Murphy SA. Examining moderated effects of additional adolescent substance use treatment: Structural nested mean model estimation using inverse-weighted regression with residuals. Technical Report 12-121, Penn State University, University Park, PA, 2012.
37. Raghunathan T, Lepkowski J, Hoewyk J, Solenberger P. A multivariate technique for multiply imputing missing values using a sequence of regression models. Survey Methodology 2001; 27:85-95.
38. Raghunathan T, Solenberger P, Hoewyk J. IVEware: Imputation and variance estimation software, Survey Research Center, Institute for Social Research, Ann Arbor, MI, 2002.
39. Rubin D. Multiple Imputation for Nonresponse in Surveys. Wiley: New York, NY, 1987.
40. Schafer J. Analysis of Incomplete Multivariate Data. Chapman and Hall / CRC Press: London, 1997.
41. McCaffrey DF, Ridgeway G, Morral AR. Propensity score estimation with boosted regression for evaluating causal effects in observational studies. Psychological Methods 2004; 9(4):403-425.
42. Dishion T, McCord J, Poulin F. When interventions harm: peer groups and problem behavior. American Psychologist 1999; 54(9):755-764.
43. Garnick D, Lee M, O'Brien P, Panas L, Ritter G, Acevedo A, Garner B, Funk R, Godley M. The washington circle engagement performance measures' association with adolescent treatment outcomes. Drug and Alcohol Dependence 2012; 124(3):250-258.
44. Williams R, Chang S. A comprehensive and comparative review of adolescent substance treatment outcome. Clinical Psychology: Science and Practice 2000; 7(2):138-166.
45. Rothman K, Greenland S. Modern Epidemiology, 2nd edn. Lippincott-Raven: Philadelphia, PA, 1998.
46. Brumback B, Berg A. On effect-measure modification: relationships among changes in the relative risk, odds ratio, and risk difference. Statistics in Medicine 2008; 27:3453-3465.
47. Vansteelandt S, Goetghebeur E. Causal inference with generalized structural mean models. Journal of the Royal Statistical Society Series B 2003; 65:817-835.
48. Robins JM, Rotnitzky A. Estimation of treatment effects in randomised trials with non-compliance and a dichotomous outcome using structural mean models. Biometrika 2004; 91:763-783.
49. Comté L, Vansteelandt S, Tousset E, Baxter G, Vrijens B. Linear and loglinear structural mean models to evaluate the benefits of an on-demand dosing regimen. Clinical Trials 2009; 6:403-415.
50. Murphy SA. Optimal dynamic treatment regimes. Journal of the Royal Statistical Society, Series B 2003; 65(2):331-366.
51. Hernán MA, Lanoy E, Costagliola D, Robins JM. Comparison of dynamic treatment regimes via inverse probability weighting. Basic and Clinical Pharmacology and Toxicology 2006; 98(3):237-242.
52. Moodie E, Richardson T, Stephens D. Demystifying optimal dynamic treatment regimes. Biometrics 2007; 63(2):447-455.
53. Orellana L, Rotnitzky A, Robins JM. Dynamic regime marginal structural mean models for estimation of optimal dynamic treatment regimes, part I: main content. International Journal of Biostatistics 2010; 6(2). Article 8.